Stress tests equipment market seen reaching $4.34 billion by 2030

The global market for stress test equipment is projected to grow from $3.19 billion in 2025 to $4.34 billion by 2030, driven by rising cardiovascular disease rates and wider use of portable and wireless cardiac testing tools. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Stress test equipment is gaining importance as health systems push earlier detection of coronary artery disease and other cardiovascular conditions. - Rising demand for portable cardiopulmonary exercise testing and wireless ECG monitoring is expanding the market beyond traditional hospital settings. - The market’s growth tracks a broader increase in cardiovascular disease, which is adding pressure on diagnostic services worldwide.

What happened: - The Business Research Company published its Stress Tests Equipment Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report pegs the market at $3.19 billion in 2025 and $3.39 billion in 2026. - The market is forecast to reach $4.34 billion by 2030, at a 6.3% compound annual growth rate. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period.

The details: - Stress tests equipment includes medical devices that evaluate cardiovascular performance under controlled physical or pharmacological stress. - The devices are used to assess heart function, detect coronary artery disease, measure exercise tolerance and evaluate cardiovascular risk factors. - The market’s recent growth has been supported by higher coronary artery disease prevalence, wider cardiovascular risk screening, and broad adoption of treadmill and ergometry-based systems. - Early use of exercise ECG and echocardiography in cardiac assessments has also supported demand. - Diagnostic cardiology services are expanding in hospitals and specialized centers. - Future growth is expected from preventive cardiology and sports medicine programs. - Adoption is also increasing in ambulatory care centers and diagnostic networks. - Emerging healthcare markets are expected to add more demand. - The report highlights a stronger clinical focus on early detection and outcome-driven cardiac risk management.

Between the lines: - The market outlook suggests stress testing is shifting from a niche diagnostic step to a broader screening and monitoring tool. - Portable and wireless systems are becoming more important as care moves closer to outpatient and distributed settings. - The regional split points to a mature market in North America and a growth runway in Asia-Pacific as healthcare infrastructure expands. - A British Heart Foundation report from September 2024 said about 7.6 million people in the UK live with heart and circulatory diseases, and that figure is projected to rise by 1 million by 2030 and another 2 million by 2040.

What's next: - The market is expected to keep growing through 2030 at a 6.3% annual pace. - CPET, wireless ECG and other portable devices are likely to gain wider use. - Stress testing should continue spreading into preventive care, sports medicine and ambulatory settings as providers prioritize earlier risk detection. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - More information is available in the free sample report and the full market report.